These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6345723)

  • 1. Schizophrenia: some current neurochemical approaches.
    Rodnight R
    J Neurochem; 1983 Jul; 41(1):12-21. PubMed ID: 6345723
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monoaminergic synapses in the brain--regulation and ontogenetic development].
    Nomura Y
    Yakugaku Zasshi; 1982 Jul; 102(7):603-16. PubMed ID: 6296351
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of amino acids, amines and neuropeptides on target cells in the mammalian central nervous system.
    Zieglgänsberger W
    Prog Brain Res; 1982; 55():297-320. PubMed ID: 6187042
    [No Abstract]   [Full Text] [Related]  

  • 4. Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development.
    Blier P
    J Psychopharmacol; 2008 Aug; 22(6):587-9. PubMed ID: 18753271
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract]   [Full Text] [Related]  

  • 6. Conformational flexibility in physiologically active amines.
    Richards WG; Aschman DG; Hammond J
    J Theor Biol; 1975 Jul; 52(1):223-30. PubMed ID: 168441
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotransmitters and sleep.
    Mendelson WB
    J Clin Psychiatry; 2001; 62 Suppl 10():5-8. PubMed ID: 11388591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biogenic monoamines and convulsion potential of the brain].
    Vediaev FP; Sergienko NG
    Usp Fiziol Nauk; 1984; 15(1):55-75. PubMed ID: 6322467
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurotransmitters and CNS disease. Schizophrenia.
    Snyder SH
    Lancet; 1982 Oct; 2(8305):970-4. PubMed ID: 6127468
    [No Abstract]   [Full Text] [Related]  

  • 10. gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia.
    Van Kammen DP
    Am J Psychiatry; 1977 Feb; 134(2):138-43. PubMed ID: 835733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemistry of the brain.
    Iversen LL
    Sci Am; 1979 Sep; 241(3):134-49. PubMed ID: 91194
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dopaminergic receptor activity and the evolution of schizophrenia].
    Fodoreanu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemistry and physiology of biogenic monoamines and their role in the origin and development of psychosis].
    Jovicić A; Nikić S; Miljanović B
    Med Pregl; 1978; 31(1-2):57-61. PubMed ID: 349342
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects.
    Murphy DL; Cohen RM; Siever LJ; Roy B; Karoum F; Wyatt RJ; Garrick NA; Linnoila M
    Mod Probl Pharmacopsychiatry; 1983; 19():287-303. PubMed ID: 6408411
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monoaminergic systems of the brain and behavior].
    Budantsev AIu; Azarashvili AA; Zharikov SI; Arkhipov VI
    Usp Fiziol Nauk; 1977; 8(2):53-74. PubMed ID: 197724
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment approaches to mania.
    Ananth J
    Int Pharmacopsychiatry; 1976; 11(4):215-31. PubMed ID: 188775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of morphine dependence on some specific effects mediated by monoaminergic and GABAergic systems.
    Buckett WR
    Psychopharmacology (Berl); 1979; 66(3):233-8. PubMed ID: 231277
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular and molecular aspects of transmitter release: calcium monoamine dynamics.
    Radouco-Thomas S
    Adv Cytopharmacol; 1971 May; 1():457-75. PubMed ID: 4148192
    [No Abstract]   [Full Text] [Related]  

  • 19. Biogenic amines in the regulation of wakefulness and sleep.
    Hilakivi I
    Med Biol; 1987; 65(2-3):97-104. PubMed ID: 3309491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of biogenic amines and cyclic nucleotides in seizure mechanisms.
    Ferrendelli JA
    Adv Neurol; 1986; 44():393-400. PubMed ID: 3706017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.